Medicine:Cancer Cells Exploit Immune Pathways to Resist Drugs: Revision history

From HandWiki

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

    13 August 2024

    • curprev 00:5000:50, 13 August 2024Catalinagarcia talk contribs 4,227 bytes +4,227 Created page with "In cancer immunotherapy, the spotlight has fallen on STING as a pivotal target of recent interest. Biopharmaceutical companies worldwide are vigorously developing innovative therapies targeting STING with the goal of activating immune pathways to combat cancer cells. While these STING agonists have demonstrated promise in preclinical studies, a perplexing phenomenon has emerged in certain clinical trials. Contrary to expectations, drugs designed to activate the STING pa..."